Clinical trial
Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
NCT00440349 · University of Parma, Other · Unknown status
Key facts
| NCT number | NCT00440349 |
|---|---|
| Title | Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis |
| Official title | A Randomised Trial of Prednisone and Tamoxifen in Patients With Idiopathic Retroperitoneal Fibrosis |
| Lead sponsor | University of Parma, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Retroperitoneal Fibrosis |
| Intervention type | Drug |
| Interventions | Tamoxifen, Prednisone |
| Enrollment | 38 |
| Start date | Oct 1, 2000 |
| Completion | Apr 1, 2007 |
| First posted | Feb 27, 2007 |
| Last update posted | Feb 27, 2007 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: